CITI/CALL/PFIZER INC/32/0.1/19.12.24 Share Price

Warrant

DE000KH9RQL6

Market Closed - Boerse Frankfurt Warrants 18:35:29 25/06/2024 BST
0.059 EUR +7.27% Intraday chart for CITI/CALL/PFIZER INC/32/0.1/19.12.24
Current month-31.40%
1 month-41.00%
Date Price Change
25/06/24 0.059 +7.27%
24/06/24 0.055 +10.00%
21/06/24 0.05 -13.79%
20/06/24 0.058 +13.73%
19/06/24 0.051 +2.00%

Real-time Boerse Frankfurt Warrants

Last update June 25, 2024 at 06:35 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Citi Citi
WKN KH9RQL
ISINDE000KH9RQL6
Date issued 13/09/2023
Strike 32 $
Maturity 19/12/2024 (177 Days)
Parity 10 : 1
Emission price 0.47
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.5
Lowest since issue 0.031

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.99 USD
Average target price
31.92 USD
Spread / Average Target
+14.02%
Consensus